Skip to main content
. Author manuscript; available in PMC: 2023 Jun 6.
Published in final edited form as: Hypertension. 2023 Mar 23;80(5):e75–e89. doi: 10.1161/HYP.0000000000000227

Reviewer Disclosures

Reviewer Employment Research grant Other research support Speakers’ bureau/honoraria Expert witness Ownership interest Consultant/advisory board Other
Tarek F. Antonios St George’s, University of London (United Kingdom) None None None None None None None
Michel Baum University of Texas Southwestern Medical Center at Dallas None None None None None None None
Hui Hu Brigham and Women’s Hospital None None None None None None None
Maris Laan University of Tartu (Estonia) Estonian Research Agency (grant EAG112 “Maternal Serum Based Multimarker Test for the Risk Assessment to Develop Preeclampsia: Translation to the Clinic [ESTPRE study]”) None None None None None None
Anne M. Nuyt Université de Montréal (Canada) None None None None None None None

This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

Significant.